Charles River Laboratories Italia Competitors and Similar CompaniesClear all
Charles River Laboratories Italia's competitors and similar companies include Gilead Sciences, Athenex, Syngene International and Nivika Chemo Pharma.
 Charles River Laboratories Italia Charles River Laboratories Italia is a company that provides biotech research and development solutions. |  Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. |  Athenex Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer. |  Syngene International Syngene International is integrated research, development, and manufacturing company providing scientific services. |  Nivika Chemo Pharma Nivika Chemo Pharma is a research and development company that offers drug development services. | |
Founding Date | Founding Date 1953 | Founding Date 1987 | Founding Date 2003 | Founding Date 1993 | Founding Date 1993 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Milano, IT HQ Calco, IT Sant'angelo Lodigiano, IT | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | Locations Bangalore, IN HQ Bangalore, IN Bengaluru, IN | Locations Ankleshwar, IN HQ | |
Employees | Employees 312 | Employees 18,0006% increase | Employees 575 | Employees 6,510 | Employees 100 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 110.5 b | Valuation ($) 2.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €32.4m (FY, 2024) | Revenue (est.) $29.4b (FY, 2025) | Revenue (est.) $102.8m (FY, 2022) | Revenue (est.) ₹37.4b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $6.2b (FY, 2025) | Cost of goods $76.1m (FY, 2022) | Cost of goods ₹9.2b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $23.2b (FY, 2025) | Gross profit $26.7m (FY, 2022) | Gross profit ₹28.9b (FY, 2026) | Gross profit N/A |
Net income | Net income €2.3m (FY, 2024) | Net income $8.5b (FY, 2025) | Net income ($104.4m) (FY, 2022) | Net income ₹3.2b (FY, 2026) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 252.1m | Total funding raised $ 62m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Gilead Sciences
HQ
Foster City, US
Employees
18,000↑ 6% increase
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
View companyAthenex
HQ
Buffalo, US
Employees
575
Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer.
View companySyngene International
HQ
Bangalore, IN
Employees
6,510
Syngene International is integrated research, development, and manufacturing company providing scientific services.
View companyNivika Chemo Pharma
HQ
Ankleshwar, IN
Employees
100
Nivika Chemo Pharma is a research and development company that offers drug development services.
View company